A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: Effect on total hospital admissions

Journal of Infectious Diseases

Volumn 209, Issue 11, 2014, Pages 1731-1738

  Martins, Cesario L ^a   Benn, Christine S ^a   Andersen, Andreas ^a   Balé, Carlito ^a   Schaltz Buchholzer, Frederik ^a   Do, Vu An ^a   Rodrigues, Amabelia ^a   Aaby, Peter ^a   Ravn, Henrik ^a   Whittle, Hilton ^b   Garly, May Lill ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Edmonston Zagreb; hospital admissions; measles infection; measles vaccination; morbidity reduction; nonspecific effects of vaccine

Indexed keywords

EDMONSTON ZAGREB; MEASLES VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GUINEA-BISSAU; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; INFANT; INFECTION PREVENTION; MALARIA; MALE; MEASLES; MEASLES VACCINATION; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SEX DIFFERENCE;

EDMONSTON-ZAGREB; HOSPITAL ADMISSIONS; MEASLES INFECTION; MEASLES VACCINATION; MORBIDITY REDUCTION; NONSPECIFIC EFFECTS OF VACCINE;

DIETARY SUPPLEMENTS; FEMALE; GUINEA-BISSAU; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; MEASLES; MEASLES VACCINE; RISK FACTORS; SEX FACTORS; VITAMIN A;

EID: 84900537134     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit804     Document Type: Article

References (44)

1. The Kasongo project team. Influence of measles vaccination on survival pattern of 7-35-month-old children in Kasongo, Zaire. Lancet 1981; 1: 764-7.
2. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and child mortality. Lancet 1981; ii: 93.
3. Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984; 8: 13-21.
4. Desgrées du LoÛ A, Pison G, Aaby P. The role of immunizations in the recent decline in childhood mortality and the changes in the female/male mortality ratio in rural Senegal. Am J Epidemiol 1995; 142: 643-52.
5. Aaby P, Samb B, Simondon F, Knudsen K, Coll Seck AM, Bennett J, Whittle H. Divergent mortality for male and female recipients of lowtitre and high-titre measles vaccines in rural Senegal. Am J Epidemiol 1993; 138: 746-55.
6. Aaby P, Bukh J, Lisse IM, Smits AJ, Gomes J, Fernandes MA, Indi F, Soares M. Determinants of measles mortality in a rural area of Guinea- Bissau: Crowding, age, and malnutrition. J Trop Pediatr 1984; 30: 164-69.
7. Aaby P, Pedersen IR, Knudsen K, et al. Child mortality related to seroconversion or lack of seroconversion after measles vaccination. Pediatr Inf Dis J 1989; 8: 197-200.
8. Holt EA, Boulos R, Halsey NA, Boulos IM, Boulos C. Childhood survival in Haiti: Protective effect of measles vaccination. Pediatrics 1990; 85: 188-94.
9. Clemens JD, Stanton BF, Chakraborty J, Chowdhury S, Rao M, Ali M. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 1988; 128: 1330-9.
10. Koenig MA, Khan MA, Wojtyniak B, et al. The impact of measles vaccination upon childhood mortality in Matlab, Bangladesh. Bull WHO 1990; 68: 441-7.
11. de Quadros CA. Can measles be eradicated globally? Bull WHO 2004; 82: 134-8.
12. Aaby P, Samb B, Simondon F, Coll Seck AM, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995; 311: 481-5.
13. Aaby P, Martins CL, Garly ML, et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: Randomised controlled trial. BMJ 2010; 341:c6495.
14. Aaby P. Bandim: an unplanned longitudinal study. In: Das Gupta M, Aaby P, Pison G, Garenne M, eds. Prospective community studies in developing countries. Oxford: Clarendon Press, 1997: 276-96.
15. Aaby P, Martins C, Bale C, et al. Sex differences in the effect of vaccines on the risk of hospitalisation due to measles in Guinea-Bissau. Pediatr Inf Dis J 2010; 29: 324-8.
16. Martins CL, Garly ML, Balé C, et al. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ 2008; 337:a661.
17. Garly M-L, Balé C, Martins CL, et al. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwartz standard titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine. Vaccine 2001; 19: 1951-9.
18. Rodrigues A, Schellenberg JA, Kofoed PE, Aaby P, Greenwood B. Changing pattern of malaria in Bissau, Guinea-Bissau. Trop Med Int Hlth 2008; 13: 410-17.
19. Ursing J, Kofoed PE, Rodrigues A, Rombo L. No seasonal accumulation of resistant P. falciparum when high-dose chloroquine is used. PLoS One 2009; 4:e6866.
20. O'Dempsey TJ, McArdle TF, Laurence BE, Lamont AC, Tood JE, Greenwood BM. Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc TropMed Hyg 1993; 87: 662-5.
21. Veirum JE, Sodemann M, Biai S, et al. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2005; 23: 1197-203.
22. Shann F. Heterologous immunity and the non-specific effects of vaccines. A major medical advance? Pediatr Inf Dis J 2004; 23: 555-8.
23. Welsh RM, Selin LH. No one is naïve: The significance of heterologus T-cell immunity. Nat Rev Immunol 2002; 2: 417-26.
24. Greenwood B. The epidemiology of pneumococcal infection in children in the developing world. Phil Trans R Soc Lond B 1999; 354: 777-85.
25. Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 2012; 109: 17537-42.
26. Aaby P, Martins CL, Garly ML, et al. Measles vaccination in the presence of maternal measles antibody associated with better child survival in two trials of early two-dose measles vaccination. (submitted).
27. Lindblad EB, Elhay MJ, Silva R, Appelberg R, Andersen P. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun 1997; 65: 623-9.
28. Barnard A, Mahon BP, Watkins J, Redhead K, Mills KH. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 1996; 87: 372-80.
29. Graham BS, Henderson GS, Tang YW, Lu X, Neuzil KM, Colley DG. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993; 151: 2032-40.
30. Fischer JE, Johnson JE, Johnson TR, Graham BS. Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection. J Infect Dis 2000; 182: 1029-38.
31. Moran TM, Park H, Fernandez-Sesma A, Schulman JL. Th2 responses to inactivated Influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection. J Infect Dis 1999; 180: 579-85.
32. Aaby P, Benn CS, Nielsen J, Lisse IM, Rodrigues A, Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative nonspecific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012; 2:e000707.
33. Benn CS, Aaby P, Nielsen J, Binka FN, Ross DA. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana vitamin A supplementation trial. Am J Clin Nut 2009; 90: 629-39.
34. Benn CS, Rodrigues A, Yazdanbakhsh M, et al. The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination. Vaccine 2009; 27: 2891-8.
35. Benn CS, Diness BR, Roth A, et al. Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 2008; 336: 1416-20.
36. Benn CS, Fisker A, Napirna BM, et al. Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ 2010; 340:c1101.
37. Fisker AB, Aaby P, Rodrigues A, Frydenberg M, Bibby BM, Benn CB. Vitamin A supplementation at birth might prime the response to subsequent vitamin A supplements in girls. Three year follow-up of a randomized trial. PLoS One 2011; 6:e23265.
38. Shaheen SO, Aaby P, Hall AJ, et al. Cell mediated immunity after measles in Guinea-Bissau: historical cohort study. BMJ 1996; 313: 969-74.
39. Lisse I, Aaby P, Whittle H, Jensen H, Engelman M, Christensen LB. Tlymphocyte subsets in West Africa children: Impact of age, sex, and season. J Pediatr 1997; 130: 77-85.
40. Martins C, Garly ML, Bale C, et al. Measles antibodies responses after Edmonston-Zagrebstandard-titremeaslesvaccinationat4=and 9months, only 9 months, or 9 and 18 months of age. J Infect Dis. In press.
41. Sørup S, Benn CS, Krause T, Aaby P, Ravn H. Reduced risk of hospital admissions due to infectious diseases after MMR-vaccination: a Danish nationwide cohort study. JAMA. In press.
42. Sørup S, Benn CS, Stensballe LG, Aaby P, Ravn H. Reduced risk of hospital admissions due to respiratory syncytial virus after MMRvaccination: a Danish nationwide cohort study. Clin Infect Dis. In press.
43. Aaby P, Martins CL, Garly ML, Rodrigues A, Benn CS, Whittle HC. The optimal age of measles immunization in low-income countries: A secondary analysis of the assumptions underlying the current policy. BMJ Open 2012; 2:e0007.
44. World Health Organization. Working Group non-specific effects of vaccines: terms of reference. Available at: http://www.who.int/entity/immuni zation/sage/SAGE-non-specific-effects-vaccines-WG-jan-2013.pdf.